View solutions

Inovotion seek partners to provide diverse, novel immuno-oncology compounds (with preclinical data available) to test their novel in ovo model. 

Simomics’ Virtual Disease Laboratory technology enables effective exploitation of in silico models, providing an online platform to explore, evidence, share and communicate the model and its results.

An end-user pharmaceutical company, able to provide access to ocular compounds and data with known in vivo/in vitro toxicity profiles, is sought to validate the model.

Collaborators are sought in any sector using aquatic animal health monitoring to assess and validate this eDNA metabarcoding technology against current practice.

Partnership is sought with a variety of users who can help further develop and validate the semi-automated ‘continual trials’ apparatus for spontaneous object recognition tasks.

Industrial partners involved in drug development and screening able to provide compounds and data are sought to help develop and validate the liver-on-a-chip platform as an effective tool for drug development.

Industrial collaborators able to provide different classes of ocular drugs and drug penetration data are sought to further validate the ex vivo porcine corneal model.

The LocoWhisk system incorporates both gait analysis and whisker movements and would benefit from further validation and commercialisation opportunities.

Industrial and academic collaborators are sought with expertise in various brain diseases and/or safety and efficacy of drug development to explore and expand the capabilities of the in silico model.

Industrial partners able to provide chemicals and expert guidance are sought to help validate CombiDART (systems to rapidly assess compounds for developmental and reproductive toxicity) to meet their end-user needs.

Transnetyx Tissue is seeking industrial and academic collaborators that require a reliable source of primary rat and mouse tissue and cells for research.

The scope of iSafeRabbit HA-QSARs, an in silico model to predict the skin/eye irritation potential of chemical substances, needs to be extended and validated against new chemicals.

Potential partners interested in adopting and trialling this software for capturing and visualising animal welfare assessment data, and willing to provide feedback to support refinement of the system are welcomed.

Moleculomics seek industry partners to help validate CRISP, a comparative in silico structural/functional platform for identifying species differences in liver activity, using in vitro and in vivo hepatotoxicity data.

Topcat are looking for partners in pain research willing to assess MouseMet and RatMet, which provide an alternative approach to NTT testing, reducing the number of interventions required.

Academic and industrial collaborators, with access to biological samples or with engineering/ software expertise, are sought to further validate and develop biosensing platform utilising plastic antibodies.